Goldman Sachs: Gilead Sciences, Inc. (NASDAQ:GILD) Is A Stock With High Consensus ROE
We recently looked at Goldman Sachs’ Stocks With Highest Consensus Returns: 42 Stocks With The Highest Consensus ROE. In this ...
The Lancet20h
Driving down the cost of biologics: lessons from a nationalised health-care system
Few treatments have revolutionised care for people with chronic inflammatory disorders more than biologic and small molecule ...
BioWorld20h
Merck’s clesrovimab tortoise to Beyfortus in RSV race?
Wall Street promptly began trying to weigh the compound’s marketplace odds after Merck & Co. Inc. detailed positive data from the phase IIb/III trial known as MK-1654-004 with clesrovimab, an ...
Hosted on MSN21h
Drugmaker Pulls Trodelvy's Bladder Cancer Approval
Sacituzumab govitecan's (Trodelvy) accelerated approval in urothelial cancer will be voluntarily withdrawn, Gilead Sciences ...
STAT22h
RFK Jr. alarms leaders in health, even many in GOP
“The RFK announcement has kind of scrambled some of the traditional thinking [about] a lot of the people that have been ...